Literature DB >> 3923697

Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.

K Søndergaard, G Schou.   

Abstract

Cox's multivariate regression model for survival data was applied to 2,012 patients with primary cutaneous melanoma in order to evaluate the relative prognostic value of numerous clinical and histological variables and to establish their prognostically most efficient combination. The material was divided into 4 groups according to the size of resection margin of the primary lesion (less than 2.0 cm, 2.0 cm, 2.1-4.9 cm, and greater than or equal to 5.0 cm). Data were analysed separately in these 4 groups and equivalent results were obtained. The risk factors were clinical stage, site of tumour, tumour thickness, level of invasion, mitotic activity, ulceration, lymphocytic reaction, predominant type of invasive tumour cell and partial regression. When accounting for these factors, histological type, nuclear pleomorphism, nucleolar size, vascular invasion, pigmentation, verrucous growth pattern, and dermal elastosis were without prognostic influence. The effect of sex and age of patient was uncertain and both variables, therefore, were retained in the model. By using Cox's method it is possible to make a qualified estimate of the survival for the individual patient.

Entities:  

Mesh:

Year:  1985        PMID: 3923697     DOI: 10.1007/bf00737084

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  29 in total

1.  Histology and prognosis in malignant melanoma.

Authors:  A J Cochran
Journal:  J Pathol       Date:  1969-03       Impact factor: 7.996

2.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

3.  The classification of melanoma and its relationship with prognosis.

Authors:  V J McGovern
Journal:  Pathology       Date:  1970-04       Impact factor: 5.306

4.  Effect of anatomical location on prognosis in patients with clinical stage I melanoma.

Authors:  G S Rogers; A W Kopf; D S Rigel; R J Friedman; J L Levine; M Levenstein; R S Bart; M M Mintzis
Journal:  Arch Dermatol       Date:  1983-08

5.  Histological type and biological behavior of primary cutaneous malignant melanoma. 2. An analysis of 86 cases located on so-called acral regions as plantar, palmar, and sub-/parungual areas.

Authors:  K Søndergaard
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

6.  Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.

Authors:  K Søndergaard
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1985-03

7.  Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.

Authors:  C L Day; M C Mihm; R A Lew; M N Harris; A W Kopf; T B Fitzpatrick; T J Harrist; F M Golomb; A Postel; P Hennessey; S L Gumport; J W Raker; R A Malt; A B Cosimi; W C Wood; D F Roses; F Gorstein; D Rigel; R J Friedman; M M Mintzis; A J Sober
Journal:  Ann Surg       Date:  1982-01       Impact factor: 12.969

8.  Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity?

Authors:  V J McGovern; H M Shaw; G W Milton; G A Farago
Journal:  Histopathology       Date:  1980-05       Impact factor: 5.087

9.  Malignant melanoma of the foot. A clinicopathological study of 125 primary cutaneous malignant melanomas.

Authors:  K Søndergaard; G Olsen
Journal:  Acta Pathol Microbiol Scand A       Date:  1980-09

10.  A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.

Authors:  C M Balch; S J Soong; T M Murad; A L Ingalls; W A Maddox
Journal:  Surgery       Date:  1979-08       Impact factor: 3.982

View more
  9 in total

1.  The significance of inflammation and regression in melanoma.

Authors:  M G Cook
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas.

Authors:  E Ralfkiaer; K Hou-Jensen; K C Gatter; K T Drzewiecki; D Y Mason
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

Authors:  Nancy E Thomas; Anne Kricker; Weston T Waxweiler; Patrick M Dillon; Klaus J Busman; Lynn From; Pamela A Groben; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Alison Venn; Peter A Kanetsky; Irene Orlow; Susan Paine; David W Ollila; Anne S Reiner; Li Luo; Honglin Hao; Jill S Frank; Colin B Begg; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2014-12       Impact factor: 10.282

4.  Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis.

Authors:  K Søndergaard; G Schou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

5.  Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases.

Authors:  K Søndergaard; K Hou-Jensen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

6.  Morphometric, DNA and PCNA in thin malignant melanomas.

Authors:  V Björnhagen; E Månsson-Brahme; J Lindholm; A Mattsson; G Auer
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

7.  Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer Immunotherapy.

Authors:  Yohsuke Yagawa; Mark Robertson-Tessi; Susan L Zhou; Alexander R A Anderson; James J Mulé; Adam W Mailloux
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

8.  Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas.

Authors:  Manuel António Campos; Sofia Macedo; Margarida Sá Fernandes; Ana Pestana; Joana Pardal; Rui Batista; João Vinagre; Agostinho Sanches; Armando Baptista; José Manuel Lopes; Paula Soares
Journal:  Genes (Basel)       Date:  2020-07-06       Impact factor: 4.096

9.  The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group.

Authors:  M Keefe; R M Mackie
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.